MedTrace Logo

Host Dysregulation-Driven Sepsis Prediction Model

NCT06523075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-10-31

No results posted yet for this study

Summary

The aim of this study is to identify risk factors associated with sepsis and to construct a predictive model for sepsis. This will provide an objective theoretical and empirical foundation for the diagnosis, assessment, and management of sepsis in our country.The primary questions addressed are:

What are the risk factors for the development of sepsis? How do we improve the prognosis of sepsis?

Conditions

Interventions

OTHER

Tumor Necrosis Factor

This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.

OTHER

Interleukin-1β

This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.

OTHER

Interleukin-12

This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.

OTHER

Interleukin-18

This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.

OTHER

Complement C3

This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.

OTHER

Complement C5

This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.

Sponsors & Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2024-10-13
Completion
2024-10-17

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06523075 on ClinicalTrials.gov